Edition:
United Kingdom

Infant Bacterial Therapeutics AB (IBTb.ST)

IBTb.ST on Stockholm Stock Exchange

178.50SEK
25 Mar 2019
Change (% chg)

-1.00kr (-0.56%)
Prev Close
179.50kr
Open
179.50kr
Day's High
179.50kr
Day's Low
175.00kr
Volume
3,054
Avg. Vol
19,157
52-wk High
207.00kr
52-wk Low
110.50kr

About

Infant Bacterial Therapeutics AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): kr749.96
Shares Outstanding(Mil.): 5.28
Dividend: --
Yield (%): --

Financials

  IBTb.ST Industry Sector
P/E (TTM): -- 29.30 32.54
EPS (TTM): -8.91 -- --
ROI: -42.09 14.23 13.82
ROE: -42.09 15.46 15.24

BRIEF-Infant Bacterial Therapeutics AB Announces First Distribution Agreement

* SIGNED FIRST DISTRIBUTION AGREEMENT FOR IBP-9414 WITH MEGAPHARM LTD. FOR THE ISRAELI MARKET AND THE PALESTINIAN AUTHORITY'S TERRITORIES

06 Mar 2019

Earnings vs. Estimates